Slowing Influenza Virus Evolution: A Role for Multiple Synergistic Antiviral Specificities in Vaccination Strategies.
作者信息
Lafont Bernard A P, Bennink Jack R
机构信息
Viral Immunology Section, NIAID, NIH, Bethesda, Maryland.
出版信息
Viral Immunol. 2020 Apr;33(3):197-200. doi: 10.1089/vim.2019.0167.
Abstract
摘要
相似文献
1
Slowing Influenza Virus Evolution: A Role for Multiple Synergistic Antiviral Specificities in Vaccination Strategies.减缓流感病毒进化：多种协同抗病毒特异性在疫苗接种策略中的作用
Viral Immunol. 2020 Apr;33(3):197-200. doi: 10.1089/vim.2019.0167.
2
Progress in the Development of Universal Influenza Vaccines.通用流感疫苗的研究进展。
Viruses. 2020 Sep 17;12(9):1033. doi: 10.3390/v12091033.
3
Overcoming Barriers in the Path to a Universal Influenza Virus Vaccine.克服通用流感病毒疫苗道路上的障碍。
Cell Host Microbe. 2018 Jul 11;24(1):18-24. doi: 10.1016/j.chom.2018.06.016.
4
Influenza vaccines: challenges and solutions.流感疫苗：挑战与解决方案。
Cell Host Microbe. 2015 Mar 11;17(3):295-300. doi: 10.1016/j.chom.2015.02.012.
5
Prospects for universal influenza virus vaccine.通用流感病毒疫苗的前景。
Emerg Infect Dis. 2006 Apr;12(4):569-74. doi: 10.3201/eid1204.051020.
6
Vaccination strategies for an influenza pandemic.流感大流行的疫苗接种策略。
J Infect Dis. 2005 Apr 15;191(8):1207-9. doi: 10.1086/428952. Epub 2005 Mar 14.
7
Influenza 1980-1.1980 - 1年流感
Br Med J. 1980 Aug 23;281(6239):527-8.
8
Stalking influenza diversity with a universal antibody.用通用抗体追踪流感病毒的多样性。
N Engl J Med. 2011 Oct 20;365(16):1541-2. doi: 10.1056/NEJMcibr1109447.
9
Tracking progress in universal influenza vaccine development.追踪通用流感疫苗研发进展。
Curr Opin Virol. 2020 Feb;40:28-36. doi: 10.1016/j.coviro.2020.02.003. Epub 2020 Apr 9.
10
Preparing for the Next Influenza Pandemic: The Development of a Universal Influenza Vaccine.为下一次流感大流行做准备：通用流感疫苗的研发。
J Infect Dis. 2019 Apr 8;219(Suppl_1):S107-S109. doi: 10.1093/infdis/jiz043.
本文引用的文献
1
Outflanking immunodominance to target subdominant broadly neutralizing epitopes.绕过免疫优势，靶向次优势广谱中和表位。
Proc Natl Acad Sci U S A. 2019 Jul 2;116(27):13474-13479. doi: 10.1073/pnas.1816300116. Epub 2019 Jun 18.
2
Human Influenza A Virus Hemagglutinin Glycan Evolution Follows a Temporal Pattern to a Glycan Limit.人类甲型流感病毒血凝素糖基进化遵循时间模式到达糖基极限。
mBio. 2019 Apr 2;10(2):e00204-19. doi: 10.1128/mBio.00204-19.
3
Sera from Individuals with Narrowly Focused Influenza Virus Antibodies Rapidly Select Viral Escape Mutations .具有 narrowly focused 流感病毒抗体的个体血清可快速选择病毒逃逸突变。
J Virol. 2018 Sep 12;92(19). doi: 10.1128/JVI.00859-18. Print 2018 Oct 1.
4
Within-Host Evolution of Human Influenza Virus.宿主内人类流感病毒的进化。
Trends Microbiol. 2018 Sep;26(9):781-793. doi: 10.1016/j.tim.2018.02.007. Epub 2018 Mar 10.
5
Immune Response to Dengue and Zika.登革热和 Zika 病毒的免疫反应
Annu Rev Immunol. 2018 Apr 26;36:279-308. doi: 10.1146/annurev-immunol-042617-053142. Epub 2018 Jan 18.
6
Contemporary H3N2 influenza viruses have a glycosylation site that alters binding of antibodies elicited by egg-adapted vaccine strains.当代 H3N2 流感病毒具有糖基化位点，该位点改变了由适应鸡蛋的疫苗株诱导的抗体的结合。
Proc Natl Acad Sci U S A. 2017 Nov 21;114(47):12578-12583. doi: 10.1073/pnas.1712377114. Epub 2017 Nov 6.
7
Parallel evolution of influenza across multiple spatiotemporal scales.流感在多个时空尺度上的平行进化。
Elife. 2017 Jun 27;6:e26875. doi: 10.7554/eLife.26875.
8
Effects of egg-adaptation on receptor-binding and antigenic properties of recent influenza A (H3N2) vaccine viruses.鸡蛋适应性对近期甲型流感（H3N2）疫苗病毒受体结合及抗原特性的影响。
J Gen Virol. 2016 Jun;97(6):1333-1344. doi: 10.1099/jgv.0.000457. Epub 2016 Mar 14.
9
Novel universal influenza virus vaccine approaches.新型通用流感病毒疫苗研发方法。
Curr Opin Virol. 2016 Apr;17:95-103. doi: 10.1016/j.coviro.2016.02.002. Epub 2016 Feb 27.
10
Deep Sequencing Reveals Potential Antigenic Variants at Low Frequencies in Influenza A Virus-Infected Humans.深度测序揭示甲型流感病毒感染人类中低频潜在抗原变异体。
J Virol. 2016 Jan 6;90(7):3355-65. doi: 10.1128/JVI.03248-15.
Zotero 插件